# FLOLAN
> **NDA020444** · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 1995-09-20
## Drug
- **FDA Application Number:** NDA020444
- **Application type:** New Drug Application
- **Brand name:** FLOLAN
- **Generic name:** EPOPROSTENOL SODIUM
- **Active ingredients:** EPOPROSTENOL SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** GLAXOSMITHKLINE LLC
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 1995-09-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020444)
---
*AI Analytics · CC0 1.0*